ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Evaluation of anti-neoplastic effects of inhibition of NFKB by DHMEQ (dehydroxymethylepoxyquinomicin) in pediatric medulloblastoma cell lines (2011)
Ramos, Priscila; Castro-Gamero,Angel Mauricio; Andrade, Augusto Faria; Borges, Kleiton da Silva; Scrideli, Carlos Alberto; Umezawa, Kazuo; Tone, Luiz Gonzaga
Source: Pediatric Blood & Cancer. Conference titles: Annual Conference of the International Society of Paediatric Oncology (SIOP). Unidade: FMRP
Subjects: NEOPLASIAS CEREBRAIS, CRIANÇAS, FÁRMACOS, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAMOS, Priscila et al. Evaluation of anti-neoplastic effects of inhibition of NFKB by DHMEQ (dehydroxymethylepoxyquinomicin) in pediatric medulloblastoma cell lines. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 18 ago. 2024. , 2011
APA
Ramos, P., Castro-Gamero, A. M., Andrade, A. F., Borges, K. da S., Scrideli, C. A., Umezawa, K., & Tone, L. G. (2011). Evaluation of anti-neoplastic effects of inhibition of NFKB by DHMEQ (dehydroxymethylepoxyquinomicin) in pediatric medulloblastoma cell lines. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Ramos P, Castro-Gamero AM, Andrade AF, Borges K da S, Scrideli CA, Umezawa K, Tone LG. Evaluation of anti-neoplastic effects of inhibition of NFKB by DHMEQ (dehydroxymethylepoxyquinomicin) in pediatric medulloblastoma cell lines. Pediatric Blood & Cancer. 2011 ; 57( 5): 806.[citado 2024 ago. 18 ]
Vancouver
Ramos P, Castro-Gamero AM, Andrade AF, Borges K da S, Scrideli CA, Umezawa K, Tone LG. Evaluation of anti-neoplastic effects of inhibition of NFKB by DHMEQ (dehydroxymethylepoxyquinomicin) in pediatric medulloblastoma cell lines. Pediatric Blood & Cancer. 2011 ; 57( 5): 806.[citado 2024 ago. 18 ]
Trabalho de evento-resumo periodico
Can zebularine be an altenative drug to tomozolomide resistant glioblastoma ? (2011)
Moreno, Daniel; Borges, Kleiton Silva; Gamero, Angel Mauricio Castro; Darrigo Júnior, Luiz Guilherme; Queiroz, Rosane Gomes de Paula; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Pediatric Blood & Cancer. Conference titles: Annual Conference of the International Society of Paediatric Oncology (SIOP). Unidade: FMRP
Subjects: CRIANÇAS, EXPRESSÃO GÊNICA, NEOPLASIAS CEREBRAIS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORENO, Daniel et al. Can zebularine be an altenative drug to tomozolomide resistant glioblastoma ?. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 18 ago. 2024. , 2011
APA
Moreno, D., Borges, K. S., Gamero, A. M. C., Darrigo Júnior, L. G., Queiroz, R. G. de P., Scrideli, C. A., & Tone, L. G. (2011). Can zebularine be an altenative drug to tomozolomide resistant glioblastoma ? Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Moreno D, Borges KS, Gamero AMC, Darrigo Júnior LG, Queiroz RG de P, Scrideli CA, Tone LG. Can zebularine be an altenative drug to tomozolomide resistant glioblastoma ? Pediatric Blood & Cancer. 2011 ; 57( 5): 805.[citado 2024 ago. 18 ]
Vancouver
Moreno D, Borges KS, Gamero AMC, Darrigo Júnior LG, Queiroz RG de P, Scrideli CA, Tone LG. Can zebularine be an altenative drug to tomozolomide resistant glioblastoma ? Pediatric Blood & Cancer. 2011 ; 57( 5): 805.[citado 2024 ago. 18 ]
Trabalho de evento-resumo periodico
Tetra-O-methyl nordihydroguaiaretic acid, a survivin inhibitor, increases growth arrest and apoptosis, reduces clonogenic capacity, and acts synergistically with temozolomide in glioblastoma cells (2011)
Castro-Gamero, Angel Mauricio; Borges, Kleiton Silva; Moreno, Daniel Antunes; Carlotti Júnior, Carlos Gilberto; Scridelli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Pediatric Blood & Cancer. Conference titles: Annual Conference of the International Society of Paediatric Oncology (SIOP). Unidade: FMRP
Subjects: NEOPLASIAS (TRATAMENTO), FÁRMACOS, PROTEÍNAS, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO-GAMERO, Angel Mauricio et al. Tetra-O-methyl nordihydroguaiaretic acid, a survivin inhibitor, increases growth arrest and apoptosis, reduces clonogenic capacity, and acts synergistically with temozolomide in glioblastoma cells. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 18 ago. 2024. , 2011
APA
Castro-Gamero, A. M., Borges, K. S., Moreno, D. A., Carlotti Júnior, C. G., Scridelli, C. A., & Tone, L. G. (2011). Tetra-O-methyl nordihydroguaiaretic acid, a survivin inhibitor, increases growth arrest and apoptosis, reduces clonogenic capacity, and acts synergistically with temozolomide in glioblastoma cells. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Castro-Gamero AM, Borges KS, Moreno DA, Carlotti Júnior CG, Scridelli CA, Tone LG. Tetra-O-methyl nordihydroguaiaretic acid, a survivin inhibitor, increases growth arrest and apoptosis, reduces clonogenic capacity, and acts synergistically with temozolomide in glioblastoma cells. Pediatric Blood & Cancer. 2011 ; 57( 5): 718.[citado 2024 ago. 18 ]
Vancouver
Castro-Gamero AM, Borges KS, Moreno DA, Carlotti Júnior CG, Scridelli CA, Tone LG. Tetra-O-methyl nordihydroguaiaretic acid, a survivin inhibitor, increases growth arrest and apoptosis, reduces clonogenic capacity, and acts synergistically with temozolomide in glioblastoma cells. Pediatric Blood & Cancer. 2011 ; 57( 5): 718.[citado 2024 ago. 18 ]
Trabalho de evento-resumo periodico
Dehydroxymethylepoxyquinomicin efficiently suppresses growth and induces apoptosis in pediatric and adult glioblastoma cell lines (2011)
Brassesco, Maria; Pezuk, Julia Alejandra; Morales, Andressa Gois; Oliveira, Jaqueline Carvalho de; Valera, Elvis Terci; Rego, Eduardo Magalhães; Carlotti Júnior, Carlos Gilberto; Umezawa, Kazuo; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Pediatric Blood & Cancer. Conference titles: Annual Conference of the International Society of Paediatric Oncology (SIOP). Unidades: FMRP, IB
Subjects: APOPTOSE, CRIANÇAS, NEOPLASIAS CEREBRAIS (TRATAMENTO), FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRASSESCO, Maria et al. Dehydroxymethylepoxyquinomicin efficiently suppresses growth and induces apoptosis in pediatric and adult glioblastoma cell lines. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 18 ago. 2024. , 2011
APA
Brassesco, M., Pezuk, J. A., Morales, A. G., Oliveira, J. C. de, Valera, E. T., Rego, E. M., et al. (2011). Dehydroxymethylepoxyquinomicin efficiently suppresses growth and induces apoptosis in pediatric and adult glioblastoma cell lines. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Brassesco M, Pezuk JA, Morales AG, Oliveira JC de, Valera ET, Rego EM, Carlotti Júnior CG, Umezawa K, Scrideli CA, Tone LG. Dehydroxymethylepoxyquinomicin efficiently suppresses growth and induces apoptosis in pediatric and adult glioblastoma cell lines. Pediatric Blood & Cancer. 2011 ; 57( 5): 803-804.[citado 2024 ago. 18 ]
Vancouver
Brassesco M, Pezuk JA, Morales AG, Oliveira JC de, Valera ET, Rego EM, Carlotti Júnior CG, Umezawa K, Scrideli CA, Tone LG. Dehydroxymethylepoxyquinomicin efficiently suppresses growth and induces apoptosis in pediatric and adult glioblastoma cell lines. Pediatric Blood & Cancer. 2011 ; 57( 5): 803-804.[citado 2024 ago. 18 ]

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects